The Vaccine Reaction

I monitor meetings of the Advisory Committee on Immunization Practices (ACIP) of the U.S. Centers for Disease Control and Prevention (CDC) for the National Vaccine Information Center (NVIC). On May 10, 2021, the U.S. Food and Drug Administration (FDA) expanded the Emergency Use Authorization (EUA) granted Pfizer/BioNTech to distribute its experimental mRNA vaccine in the U.S. to include administration to children as young as 12 years old.1 On May 12, 2021, I listened to the emergency meeting at which the ACIP voted 14-0 with one abstention (due to conflicts of interest) to recommend the Pfizer vaccine for adolescent children.2


Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *